Chanakarn Suebthawinkul

Prof. Chanakarn Suebthawinkul

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2018 in Climacteric
Verified
Journal Article
Closed access
CSChanakarn Suebthawinkul
Chanakarn Suebthawinkul
KPK. Panyakhamlerd
K. Panyakhamlerd
PYP. Yotnuengnit
P. Yotnuengnit
ASA. Suwan
A. Suwan
NCN. Chaiyasit
N. Chaiyasit
NTN. Taechakraichana
N. Taechakraichana
Background: Low serum 25-hydroxyvitamin D [25(OH)D] has been shown to be associated with low muscle mass and loss of muscle strength, resulting in increased disability and frailty in older men and women. Vitamin D deficiency is common in postmenopausal women. The primary objective of the present study was to evaluate the effects of vitamin D supplementation on muscle strength in early postmenopausal women. The effects of vitamin D2 supplementation on muscle mass and muscle cross-sectional area (CSA) were secondarily investigated. Methods: A 12-week, prospective, randomized, double-blind, placebo-controlled trial was conducted in early postmenopausal women (45–60 years old) with vitamin D deficiency (serum 25(OH)D < 20 ng/ml). A total of 88 subjects were randomized into group I: vitamin D2 supplement 40 000 IU/week (n = 44), or group II: placebo (n = 44). Serum 25(OH)D level, muscle strength, muscle mass and muscle CSA were assessed at baseline and 12 weeks after the supplementation. Results: After 12 weeks of supplementation, 70% of women in group I achieved a sufficient level of serum 25(OH)D (>30 ng/ml). There were significant differences in changes of serum 25(OH)D levels between the two groups (p < 0.05). Muscle strength and muscle CSA in group I increased significantly after 12 weeks (p = 0.015, 0.045, respectively). However, there were no significant differences in the mean changes of muscle strength, muscle mass and muscle CSA between the two groups (p = 0.16, 0.89, 0.84, respectively). Conclusion: In this study, we found no obvious effect of vitamin D supplementation on the changes in muscle strength, muscle mass and muscle CSA when compared to placebo. However, there were significant changes in muscle strength and muscle CSA from baseline in the vitamin D supplementation group.

4 April 2023 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Open access
PDF file
CSChanakarn Suebthawinkul
Chanakarn Suebthawinkul
EBElnur Babayev
Elnur Babayev
HLHoi Chang Lee
Hoi Chang Lee
FDFrancesca Duncan
Francesca Duncan
Introduction: Morphokinetic analysis using a closed time-lapse monitoring system (EmbryoScope + ™) provides quantitative metrics of meiotic progression and cumulus expansion. The goal of this study was to use a physiologic aging mouse model, in which egg aneuploidy levels increase, to determine whether there are age-dependent differences in morphokinetic parameters of oocyte maturation. Methods: Denuded oocytes and intact cumulus-oocyte complexes (COCs) were isolated from reproductively young and old mice and in vitro matured in the EmbryoScope + ™. Morphokinetic parameters of meiotic progression and cumulus expansion were evaluated, compared between reproductively young and old mice, and correlated with egg ploidy status. Results: Oocytes from reproductively old mice were smaller than young counterparts in terms of GV area (446.42 ± 4.15 vs. 416.79 ± 5.24 µm2, p < 0.0001) and oocyte area (4195.71 ± 33.10 vs. 4081.62 ± 41.04 µm2, p < 0.05). In addition, the aneuploidy incidence was higher in eggs with advanced reproductive age (24–27% vs. 8–9%, p < 0.05). There were no differences in the morphokinetic parameters of oocyte maturation between oocytes from reproductively young and old mice with respect to time to germinal vesicle breakdown (GVBD) (1.03 ± 0.03 vs. 1.01 ± 0.04 h), polar body extrusion (PBE) (8.56 ± 0.11 vs. 8.52 ± 0.15 h), duration of meiosis I (7.58 ± 0.10 vs. 7.48 ± 0.11 h), and kinetics of cumulus expansion (0.093 ± 0.002 vs. 0.089 ± 0.003 µm/min). All morphokinetic parameters of oocyte maturation were similar between euploid and aneuploid eggs irrespective of age. Conclusion: There is no association between age or ploidy and the morphokinetics of mouse oocyte in vitro maturation (IVM). Future studies are needed to evaluate whether there is an association between morphokinetic dynamics of mouse IVM and embryo developmental competence.

7 January 2025 in Journal of Imaging
Verified
Journal Article
Open access
PDF file
KOKrittapat Onthuam
Krittapat Onthuam
NCNorrawee Charnpinyo
Norrawee Charnpinyo
KSKornrapee Suthicharoenpanich
Kornrapee Suthicharoenpanich
SESupphaset Engphaiboon
Supphaset Engphaiboon
PSPunnarai Siricharoen
Punnarai Siricharoen
CSChanakarn Suebthawinkul
Chanakarn Suebthawinkul
The current process of embryo selection in in vitro fertilization is based on morphological criteria; embryos are manually evaluated by embryologists under subjective assessment. In this study, a deep learning-based pipeline was developed to classify the viability of embryos using combined inputs, including microscopic images of embryos and additional features, such as patient age and developed pseudo-features, including a continuous interpretation of Istanbul grading scores by predicting the embryo stage, inner cell mass, and trophectoderm. For viability prediction, convolution-based transferred learning models were employed, multiple pretrained models were compared, and image preprocessing techniques and hyperparameter optimization via Optuna were utilized. In addition, a custom weight was trained using a self-supervised learning framework known as the Simple Framework for Contrastive Learning of Visual Representations (SimCLR) in cooperation with generated images using generative adversarial networks (GANs). The best model was developed from the EfficientNet-B0 model using preprocessed images combined with pseudo-features generated using separate EfficientNet-B0 models, and optimized by Optuna to tune the hyperparameters of the models. The designed model’s F1 score, accuracy, sensitivity, and area under curve (AUC) were 65.02%, 69.04%, 56.76%, and 66.98%, respectively. This study also showed an advantage in accuracy and a similar AUC when compared with the recent ensemble method.

1 November 2023 in Molecular Human Reproduction
Verified
Journal Article
Closed access
PDF file
SDShweta S Dipali
Shweta S Dipali
CSChanakarn Suebthawinkul
Chanakarn Suebthawinkul
JBJoanna E. Burdette
Joanna E. Burdette
MPMaryEllen Pavone
MaryEllen Pavone
FDFrancesca Duncan
Francesca Duncan
Follicular fluid (FF) is a primary microenvironment of the oocyte within an antral follicle. Although several studies have defined the composition of human FF in normal physiology and determined how it is altered in disease states, the direct impacts of human FF on the oocyte are not well understood. The difficulty of obtaining suitable numbers of human oocytes for research makes addressing such a question challenging. Therefore, we used a heterologous model in which we cultured mouse oocytes in human FF. To determine whether FF has dose-dependent effects on gamete quality, we performed in vitro maturation of denuded oocytes from reproductively young mice (6–12 weeks) in 10%, 50%, or 100% FF from participants of mid-reproductive age (32–36 years). FF impacted meiotic competence in a dose-dependent manner, with concentrations >10% inhibiting meiotic progression and resulting in spindle and chromosome alignment defects. We previously demonstrated that human FF acquires a fibro-inflammatory cytokine signature with age. Thus, to determine whether exposure to an aging FF microenvironment contributes to the age-dependent decrease in gamete quality, we matured denuded oocytes and cumulus–oocyte complexes (COCs) in FF from reproductively young (28–30 years) and old (40–42 years) participants. FF decreased meiotic progression of COCs, but not oocytes, from reproductively young and old (9–12 months) mice in an age-dependent manner. Moreover, FF had modest age-dependent impacts on mitochondrial aggregation in denuded oocytes and cumulus layer expansion dynamics in COCs, which may influence fertilization or early embryo development. Overall, these findings demonstrate that acute human FF exposure can impact select markers of mouse oocyte quality in both dose- and age-dependent manners.

1 October 2024
Verified
Journal Article
Open access
CSChanakarn Suebthawinkul
Chanakarn Suebthawinkul
PNPranee Numchaisrika
Pranee Numchaisrika
ACAkarawin Chaengsawang
Akarawin Chaengsawang
VPVijakhana Pilaisangsuree
Vijakhana Pilaisangsuree
SSSadanan Summat
Sadanan Summat
WSWisan Sereepapong
Wisan Sereepapong
Background: Frozen embryo transfer (FET) has been increasingly used due to advancements in cryopreservation techniques and the safety advantages. This study aims to determine various factors influencing the successful FET. Materials and Methods: Retrospective cohort analysis included 1112 women who underwent programmed FET between January 2012 and October 2022, at King Chulalongkorn Memorial Hospital, Thailand. Patient characteristics, embryo characteristics, endometrial preparation protocol, endometrial characteristics (thickness, pattern), embryo transfer procedure (tip and flow during transfer, embryo placement location, the difficulty of the procedure, presence of blood and mucous at catheter), and operator factor were analyzed. Multiple logistic regression analysis was used to assess the relationship between collected variables and successful embryo transfer which is defined by clinical pregnancy. Results: The overall clinical pregnancy rate was 34.2%. Women aged 35-40 years and >40 years were less likely to have a clinical pregnancy compared to those aged <35 years [adjusted odds ratio (aOR): 0.523; 95% confidence intervals (CI): 0.360-0.757, P<0.001 and aOR: 0.260; 95% CI: 0.152-0.434, P= 25 kg/m(2) were significantly associated with decreased clinical pregnancy (aOR: 0.632; 95% CI: 0.403-0.978, P=0.042) compared to those with normal BMI. Day-3 and day-4 embryo transfer showed a significant decrease in clinical pregnancy compared to blastocyst transfer (aOR: 0.294; 95% CI: 0.173-0.485, P<0.001 and aOR: 0.497; 95% CI: 0.265-0.900, P=0.024). Double embryo transfer (DET) was 1.78 times more likely to have a clinical pregnancy than women with single embryo transfer (SET) (aOR: 1.779; 95% CI: 1.293-2.458, P<0.001). The cycles with endometrial thickness = 8 mm (aOR: 0.443; 95% CI: 0.225-0.823, P=0.013). Conclusion: Older age, obesity, non-blastocyst transfer, single embryo transfer, and endometrial thickness of <8 mm were significantly associated with a decreased clinical pregnancy in programmed FET.

11 March 2025 in Journal of Reproduction & Infertility
Verified
Journal Article
Open access
CSChanakarn Suebthawinkul
Chanakarn Suebthawinkul
PNPranee Numchaisrika
Pranee Numchaisrika
ACAkarawin Chaengsawang
Akarawin Chaengsawang
VPVijakhana Pilaisangsuree
Vijakhana Pilaisangsuree
SSSadanan Summat
Sadanan Summat
WSWisan Sereepapong
Wisan Sereepapong
Background: Fresh embryo transfer has been decreasing because of advancements in vitrification techniques and safety concerns related to ovarian hyperresponse. However, in normal responders, clinical outcomes appear to be comparable with those with frozen embryo transfer. This study aimed to determine factors that influence successful fresh embryo transfer. Methods: This retrospective cohort study included 521 women who underwent in vitro fertilization (IVF) and fresh embryo transfer at King Chulalongkorn Memorial Hospital, Thailand. Patients’ clinical data, embryo details, endometrial characteristics (thickness and pattern), and embryo transfer procedures (tip and flow during transfer, embryo placement location, difficulty of the procedure, and presence of blood and mucous at catheter) were analyzed. Chi-square test, Fisher’s exact test, Student’s t-test, and logistic regression were performed for data analysis. A p-value of 40 years were less likely to have a clinical pregnancy than those aged <35 years (adjusted odds ratio [aOR] 0.422; 95% confidence intervals [CI] 0.196-0.908, p=0.027). Day 3 embryo transfer showed a significant decrease in clinical pregnancy compared with blastocyst transfer (aOR 0.514; 95%CI 0.287-0.923, p=0.026). In the subgroup analysis for blastocyst transfer, women with good-quality blastocyst (≥322) were 2.439 times more likely to have a clinical pregnancy than those with poor-quality blastocysts (aOR 2.439; 95%CI 1.199-4.962, p=0.014). Conclusion: Advanced age and day 3 embryo transfer were significantly associated with low clinical pregnancy rates in fresh embryo transfer